German Aortic Center, Department of Vascular Medicine, University Heart Center, Hamburg, Germany; Department of Vascular Surgery, University Hospital, LMU Munich, Munich, Germany.
Aortic Center, Department of Aortic and Vascular Surgery, Hospital Marie Lannelongue, INSERM UMR_S 999, Universite Paris Sud, Le Plessis-Robinson, France.
J Vasc Surg. 2020 Jun;71(6):1825-1833. doi: 10.1016/j.jvs.2019.08.261. Epub 2020 Feb 17.
The aim of our study was to evaluate patients who underwent extensive endovascular aortic stent graft coverage (from the aortic arch to abdominal aorta) in terms of early and midterm clinical outcomes.
A retrospective multicenter study was undertaken. All patients were treated with extensive endovascular aortic stent graft coverage with fenestrated and branched endografts at three experienced endovascular centers.
Between 2012 and 2017, there were 33 patients (22 male [67%]) treated with a combination of fenestrated-branched stent grafts in the aortic arch and the thoracoabdominal aorta. Most of the patients (20/33 [61%]) had fenestrated-branched endovascular aneurysm repair (fb-EVAR) of the thoracoabdominal aorta as a second-stage procedure after thoracic arch (fb-Arch) repair, 10 had fb-Arch repair as the first procedure, and three patients had a single-stage procedure. The mean age was 67 ± 13 years, and the mean interval between procedures was 13 ± 12 months. For fb-Arch repair, 20 fenestrated and 13 branched devices were used; for fb-EVAR, 23 fenestrated, 5 branched, and 5 composite devices were used. The use of spinal drainage was more common in fb-EVAR (20/33 [61%]). Technical success was 100%. Mean hospital stay was 15 ± 13 days for fb-Arch repair and 12 ± 9 days for fb-EVAR. Two patients died in the hospital after fb-EVAR, resulting in a 30-day mortality of 6% (2/33). No deaths occurred during the fb-Arch repair component or in the single-stage cases. Four patients developed spinal cord injury (12%), 1 had permanent paraplegia (3%), and 2 patients had a neurologic event (1 stroke [3%] and 1 transient ischemic attack [3%]). Six patients (18%) died during a mean follow-up of 23 ± 17 months. The survival at 12 months after the second procedure was 72%, and the freedom from any reintervention was 82%. The 12-month freedom from reintervention was 87% for fb-Arch repair and 81% for fb-EVAR.
Extensive endovascular coverage of the aorta for aortic disease seems to be a feasible procedure in experienced centers, with acceptable perioperative morbidity and mortality. Spinal cord ischemia appears acceptable despite extensive aortic coverage.
本研究旨在评估接受广泛血管内主动脉支架移植物覆盖(从主动脉弓至腹主动脉)的患者的早期和中期临床结果。
进行了一项回顾性多中心研究。所有患者均在三个有经验的血管内中心接受血管内主动脉支架移植物覆盖联合开窗和分支内移植物治疗。
2012 年至 2017 年间,共有 33 例患者(22 例男性[67%])接受了主动脉弓和胸腹主动脉的开窗和分支支架移植物联合治疗。大多数患者(20/33 [61%])在胸主动脉弓修复(fb-Arch)后进行胸主动脉夹层动脉瘤腔内修复术(fb-EVAR)的二期治疗,10 例进行 fb-Arch 一期手术,3 例进行一期手术。患者平均年龄为 67±13 岁,两次手术之间的平均间隔为 13±12 个月。对于 fb-Arch 修复,使用了 20 个开窗和 13 个分支装置;对于 fb-EVAR,使用了 23 个开窗、5 个分支和 5 个复合装置。脊髓引流在 fb-EVAR 中更为常见(20/33 [61%])。技术成功率为 100%。fb-Arch 修复的平均住院时间为 15±13 天,fb-EVAR 的平均住院时间为 12±9 天。2 例 fb-EVAR 术后住院死亡,30 天死亡率为 6%(2/33)。fb-Arch 修复或一期手术无死亡。4 例发生脊髓损伤(12%),1 例永久性截瘫(3%),2 例发生神经系统事件(1 例中风[3%]和 1 例短暂性脑缺血发作[3%])。6 例(18%)在平均 23±17 个月的随访期间死亡。第二次手术后 12 个月的生存率为 72%,无再次干预的生存率为 82%。fb-Arch 修复的 12 个月无再次干预生存率为 87%,fb-EVAR 的 12 个月无再次干预生存率为 81%。
在有经验的中心,主动脉疾病的广泛血管内覆盖似乎是一种可行的手术,围手术期发病率和死亡率可接受。尽管主动脉广泛覆盖,但脊髓缺血似乎是可以接受的。